Understanding Risk Management for SaMD
Practical guidance on SaMD risk management under EU MDR — from component-level hazard identification to Post-Market Surveillance and ISO 14971 traceability.
For SaMD teams where speed to market is business-critical
Our approach inverts the standard certification model to eliminate the sequential delays that slow most SaMD approvals. Complete the form to find out if your product qualifies for a Free Feasibility Review.
To discover whether this service is right for you, we offer a free, no-obligation Feasibility Review.
Complete the form and a member of our team will be in touch to arrange your review.
I would recommend Mantra Systems without hesitation to any software medical device company looking for a regulatory partner that combines genuine MDR depth with a real-world understanding of software.
Sarankan Sivakanesan COO & Co-Founder Noteless
Not only were Mantra Systems very easy to work with, but their clinical knowledge and dedication to helping us meet the tight timelines for response was top notch.
Courtney Regulatory Affairs Manager Northgate Technologies
Working with hundreds of innovators revealed a consistent demand for faster, more streamlined routes to market. Rather than accept lengthy timelines as inevitable, we identified the root causes and built a service specifically designed to eliminate them.
The most common culprits are inadequate preparation, incomplete technical files, weak clinical evidence, a disconnected QMS, and a sequential process where submissions, reviews, and responses happen one after another — each adding weeks or months to the timeline.
We invert the standard model. Strategy, QMS, and technical file development are fully integrated from the outset, ISO 13485, 14971, and 62304 compliance is embedded throughout, and document review cycles run concurrently rather than sequentially — removing the bottlenecks that cause the most significant delays.
Also, with over 300 successful MDR submissions and a deep experience in supporting SaMD and AIaMD products through UK and EU MDR certification, we know what it takes to get approval.
Our clients have achieved full approval up to 3x faster than the industry standard. Class I devices have reached market in under four weeks, though timelines vary depending on device classification and complexity.
We offer a free SaMD Acceleration Feasibility Review to help assess your pathway and identify where time can be saved. Contact our team to arrange your Feasibility Review.
Practical guidance on SaMD risk management under EU MDR — from component-level hazard identification to Post-Market Surveillance and ISO 14971 traceability.
Most SaMD developers make avoidable mistakes that add months to approval. Here's what they are and how to sidestep them.
A practical guide to understanding why non-conformities happen, the most common issues in medical device submissions, and how to resolve them efficiently to get you back on track.